APA

Tagscherer K. E., Fassl A., Campos B., Farhadi M., Kraemer A., Böck B. C., Macher-Goeppinger S., Radlwimmer B., Wiestler O. D., Herold-Mende C. & Roth W. (20081118). Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. : Oncogene.

Chicago

Tagscherer K E, Fassl A, Campos B, Farhadi M, Kraemer A, Böck B C, Macher-Goeppinger S, Radlwimmer B, Wiestler O D, Herold-Mende C and Roth W. 20081118. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. : Oncogene.

Harvard

Tagscherer K. E., Fassl A., Campos B., Farhadi M., Kraemer A., Böck B. C., Macher-Goeppinger S., Radlwimmer B., Wiestler O. D., Herold-Mende C. and Roth W. (20081118). Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. : Oncogene.

MLA

Tagscherer K E, Fassl A, Campos B, Farhadi M, Kraemer A, Böck B C, Macher-Goeppinger S, Radlwimmer B, Wiestler O D, Herold-Mende C and Roth W. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. : Oncogene. 20081118.